0.6 C
New York
Sunday, December 21, 2025

When Big Pharma Spends More on Stock Buybacks Than R&D

The 14 largest publicly-traded pharmaceutical companies spent $747 billion on stock buybacks and dividends from 2012 through 2021 — substantially …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

149,801FansLike
396,312FollowersFollow
2,560SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x